PolyGene AG Information

The core business of PolyGene is the generation and analysis of genetically modified animals for R&D purposes. Customized services include molecular biology technologies, such as vector cloning and cell biology services, such as gene targeting in embryonic stem (ES) cells or micro-injection of transgenes or ES-cells into zygotes or blastocysts. State-of-the-art technologies cover the injection of TALENs for the generation of knockout / -in animals.Founded in 2002, PolyGene is run by a team of scientists with academic and industrial backgrounds. PolyGene is a privately held SME, located in the area of Zurich, Switzerland. PolyGene actively seeks participation as a SME partner within Horizon2020 projects.

Website	https://www.polygene.ch
Revenue	$7.9 million
Employees	5 (4 on RocketReach)
Founded	2002
Address	Riedmattstrasse 9, Rümlang, Zurich 8153, CH
Phone	+41 44 818 88 00
Technologies	JavaScript , HTML , PHP +14 more (view full list)
Industry	Biotechnology, Business Services General, Business Services, Science and Engineering, Discovery Tools (Healthcare), Industrial
Web Rank	3 Million
Keywords	Transgenic Animals, Genome Editing, Animal Models, Gene Modification, Biotechnology Research, Research Models, R&D Services, Molecular Biology, Genetic Engineering, In Vivo Models, Life Sciences Research, Drug Discovery, Genetic Analysis, Biomedical Research, Scientific Services
Competitors	BASF, DuPont, Avery Dennison, COVESTRO ELASTOMERS SAS, Milliken & Company, Wacker Biotech US, Archroma, Lenzing Group, Teijin Limited, Nylstar +31 more (view full list)
SIC	SIC Code 873 Companies, SIC Code 87 Companies
NAICS	NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies